BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25036775)

  • 1. Lighting up FGFR signaling.
    Zhang K; Cui B
    Chem Biol; 2014 Jul; 21(7):806-8. PubMed ID: 25036775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal control of fibroblast growth factor receptor signals by blue light.
    Kim N; Kim JM; Lee M; Kim CY; Chang KY; Heo WD
    Chem Biol; 2014 Jul; 21(7):903-12. PubMed ID: 24981772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optogenetic Control of Fibroblast Growth Factor Receptor Signaling.
    Kim N; Kim JM; Heo WD
    Methods Mol Biol; 2016; 1408():345-62. PubMed ID: 26965135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
    Lopez ME; Korc M
    J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptors have different signaling and mitogenic potentials.
    Wang JK; Gao G; Goldfarb M
    Mol Cell Biol; 1994 Jan; 14(1):181-8. PubMed ID: 8264585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
    Zhang K; Chu K; Wu X; Gao H; Wang J; Yuan YC; Loera S; Ho K; Wang Y; Chow W; Un F; Chu P; Yen Y
    Cancer Res; 2013 Feb; 73(4):1298-307. PubMed ID: 23393200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor receptor signaling crosstalk in skeletogenesis.
    Miraoui H; Marie PJ
    Sci Signal; 2010 Nov; 3(146):re9. PubMed ID: 21045207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor signaling in Caenorhabditis elegans.
    Borland CZ; Schutzman JL; Stern MJ
    Bioessays; 2001 Dec; 23(12):1120-30. PubMed ID: 11746231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.
    Cross MJ; Lu L; Magnusson P; Nyqvist D; Holmqvist K; Welsh M; Claesson-Welsh L
    Mol Biol Cell; 2002 Aug; 13(8):2881-93. PubMed ID: 12181353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
    Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
    Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
    Helsten T; Schwaederle M; Kurzrock R
    Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma.
    Ilyas SI; Yamada D; Hirsova P; Bronk SF; Werneburg NW; Krishnan A; Salim W; Zhang L; Trushina E; Truty MJ; Gores GJ
    J Biol Chem; 2016 Apr; 291(15):8031-47. PubMed ID: 26826125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optogenetic Approaches for the Spatiotemporal Control of Signal Transduction Pathways.
    Kramer MM; Lataster L; Weber W; Radziwill G
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation of poorly differentiated endometrial cancer cells through autocrine activation of FGF receptor and HES1 expression.
    Mori M; Mori T; Yamamoto A; Takagi S; Ueda M
    Hum Cell; 2019 Jul; 32(3):367-378. PubMed ID: 30963412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule inhibition of fibroblast growth factor receptors in cancer.
    Liang G; Chen G; Wei X; Zhao Y; Li X
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for targeting fibroblast growth factor receptor signaling in breast cancer.
    André F; Cortés J
    Breast Cancer Res Treat; 2015 Feb; 150(1):1-8. PubMed ID: 25677745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF/FGFR signaling in bone formation: progress and perspectives.
    Marie PJ; Miraoui H; Sévère N
    Growth Factors; 2012 Apr; 30(2):117-23. PubMed ID: 22292523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
    Dianat-Moghadam H; Teimoori-Toolabi L
    Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-binding specificity of human fibroblast growth factor receptor-3 IIIc.
    Lin HY; Kaplow J; Jaye M; Hayman MJ
    FEBS Lett; 1997 Jul; 411(2-3):389-92. PubMed ID: 9271242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder.
    Roskoski R
    Pharmacol Res; 2020 Jan; 151():104567. PubMed ID: 31770593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.